Literature DB >> 26362479

Lipid-PEG conjugates sterically stabilize and reduce the toxicity of phytantriol-based lyotropic liquid crystalline nanoparticles.

Jiali Zhai1, Tracey M Hinton2, Lynne J Waddington3, Celesta Fong1,4, Nhiem Tran1, Xavier Mulet1, Calum J Drummond4, Benjamin W Muir1.   

Abstract

Lyotropic liquid crystalline nanoparticle dispersions are of interest as delivery vectors for biomedicine. Aqueous dispersions of liposomes, cubosomes, and hexosomes are commonly stabilized by nonionic amphiphilic block copolymers to prevent flocculation and phase separation. Pluronic stabilizers such as F127 are commonly used; however, there is increasing interest in using chemically reactive stabilizers for enhanced functionalization and specificity in therapeutic delivery applications. This study has explored the ability of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine conjugated with poly(ethylene glycol) (DSPE-PEGMW) (2000 Da ≤ MW ≤ 5000 Da) to engineer and stabilize phytantriol-based lyotropic liquid crystalline dispersions. The poly(ethylene glycol) (PEG) moiety provides a tunable handle to the headgroup hydrophilicity/hydrophobicity to allow access to a range of nanoarchitectures in these systems. Specifically, it was observed that increasing PEG molecular weight promotes greater interfacial curvature of the dispersions, with liposomes (Lα) present at lower PEG molecular weight (MW 2000 Da), and a propensity for cubosomes (QII(P) or QII(D) phase) at MW 3400 Da or 5000 Da. In comparison to Pluronic F127-stabilized cubosomes, those made using DSPE-PEG3400 or DSPE-PEG5000 had enlarged internal water channels. The toxicity of these cubosomes was assessed in vitro using A549 and CHO cell lines, with cubosomes prepared using DSPE-PEG5000 having reduced cytotoxicity relative to their Pluronic F127-stabilized analogues.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26362479     DOI: 10.1021/acs.langmuir.5b02797

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  10 in total

Review 1.  Cubosomes: The Next Generation of Smart Lipid Nanoparticles?

Authors:  Hanna M G Barriga; Margaret N Holme; Molly M Stevens
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-26       Impact factor: 15.336

Review 2.  Gold nanoparticles to enhance ophthalmic imaging.

Authors:  Fang Chen; Peng Si; Adam de la Zerda; Jesse V Jokerst; David Myung
Journal:  Biomater Sci       Date:  2020-10-15       Impact factor: 6.843

3.  Preparation, Synergism, and Biocompatibility of in situ Liquid Crystals Loaded with Sinomenine and 5-Fluorouracil for Treatment of Liver Cancer.

Authors:  Jiaojiao Cao; Jie Huang; Shuangying Gui; Xiaoqin Chu
Journal:  Int J Nanomedicine       Date:  2021-05-31

Review 4.  Janus particles: recent advances in the biomedical applications.

Authors:  Tu C Le; Jiali Zhai; Wei-Hsun Chiu; Phong A Tran; Nhiem Tran
Journal:  Int J Nanomedicine       Date:  2019-08-23

Review 5.  Toxicity of gold nanoparticles (AuNPs): A review.

Authors:  A Sani; C Cao; D Cui
Journal:  Biochem Biophys Rep       Date:  2021-04-10

Review 6.  Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.

Authors:  Maria Chountoulesi; Stergios Pispas; Ioulia K Tseti; Costas Demetzos
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-31

7.  Scalable hybrid chemical manufacture to photothermal therapy: PEG-capped phototransducers.

Authors:  Jeong Hoon Byeon
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

8.  Non-Lamellar Liquid Crystalline Nanocarriers for Thymoquinone Encapsulation.

Authors:  Anan Yaghmur; Boi Vi Tran; Seyed Moein Moghimi
Journal:  Molecules       Date:  2019-12-19       Impact factor: 4.411

Review 9.  Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review.

Authors:  Yosif Almoshari
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

10.  Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.

Authors:  Jia Liu; Hao Cheng; Le Han; Zhun Qiang; Xinwei Zhang; Wei Gao; Kun Zhao; Yangrong Song
Journal:  Drug Des Devel Ther       Date:  2018-09-25       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.